Showing results (31-40 of 45) with videos related to
Sort By:
Pageof 5
Clinical Reviews in Allergy & Immunology|April 27, 2010
Rituximab therapy in lupus nephritis: current clinical evidenceManuel Ramos-Casals, Candido Diaz-Lagares, Maria-Jose Soto-Cardenas, et al.Medicine|November 18, 2008
Acute viral infections in patients with systemic lupus erythematosus: description of 23 cases and review of the literatureManuel Ramos-Casals, María José Cuadrado, Paula Alba, et al.World Journal of Gastroenterology|September 29, 2006
Successful outcome after combined chemotherapeutic and surgical management in a case of esophageal cancer with breast and brain relapseDavide Adriano Santeufemia, Gianfranca Piredda, Giovanni Maria Fadda, et al.Tumori|January 31, 2007
Small cell lung cancer in a young patient with osteopetrosisGiovanni Maria Fadda, Davide Adriano Santeufemia, Paolo Cossu Rocca, et al.Oncology Letters|July 23, 2016
Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinomaGrazia Palomba, Antonio Cossu, Panagiotis Paliogiannis, et al.Arthritis and Rheumatism|December 31, 2005
Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysisFotini B Karassa, Antonella Afeltra, Ales Ambrozic, et al.Journal of Translational Medicine|October 15, 2016
Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based studyGrazia Palomba, Valentina Doneddu, Antonio Cossu, et al.Journal of Translational Medicine|August 31, 2012
Prevalence of KRAS, BRAF, and PIK3CA somatic mutations in patients with colorectal carcinoma may vary in the same population: clues from SardiniaGrazia Palomba, Maria Colombino, Antonio Contu, et al.The Lancet. Oncology|September 20, 2021
Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: a multicentre, open-label, randomised, phase 3 trialLucia Del Mastro, Mauro Mansutti, Giancarlo Bisagni, et al.Research and Practice in Thrombosis and Haemostasis|August 14, 2024
Rivaroxaban for stroke patients with antiphospholipid syndrome (RISAPS): protocol for a randomized controlled, phase IIb proof-of-principle trialPrabal Mittal, Rafael Gafoor, Zara Sayar, et al.Pageof 5